Redefining neuroscience research & development by tackling the brain disease heterogeneity problem
Learning from the revolution in precision oncology, we aim to overcome the historical challenges of drug development for brain diseases by developing precision medicines. To develop targeted medicines, we need to deeply understand the multiple drivers of brain diseases. Instead of taking brain biopsies, our solution is to develop proprietary Data Biopsies™ by integrating multiple data types to provide a more complete picture of the specific mechanisms that drive brain diseases in specific patient populations.
Our Solution: Data Biopsy Signatures™
To cut through the heterogeneity of neuropsychiatric disorders and neurodegenerative diseases, Neumora’s scalable data sciences platform is designed to identify and define patient subtypes by mapping the mechanisms that drive brain diseases through the development of Data Biopsy Signatures.